Responsibility in Drug Advertising Act of 2025

House Votes

This bill limits ads for new prescription drugs that target consumers. For the first three years after a drug gets FDA approval, drug companies could not run direct-to-consumer ads, including on social media. The FDA could allow ads during the third year if it decides they would help public health. The FDA could also keep ads off the air even after three years if new safety data shows serious risks. The FDA must update its advertising rules within one year to make these changes work. These limits apply to drugs approved starting one year before the law takes effect.

Key points:

• Who is affected: Drug makers, advertisers, and people who see drug ads on TV, online, and social media.
• What changes: A 3-year ban on consumer drug ads; possible FDA waiver in year 3; possible ad bans beyond 3 years if serious side effects emerge; includes social media.
• When: Applies to drugs approved starting one year before the law’s enactment; FDA must update rules within one year.